임신 중 진단된 갑상선유두암의 외과적 치료 시기
Timing of Surgical Management of Papillary Thyroid Cancer Diagnosed during Pregnancy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Objectives: Although the thyroid cancer occurs in every one of 1000 pregnant women, the optimal timing of surgery is still uncertain. The aim of this study is to propose the timing of surgical management of papillary thyroid cancer in pregnant woman. Materials and Methods: The authors reviewed the medical records of papillary thyroid cancer patients diagnosed during pregnancy in our hospital from May 1st, 2013 to April 30th, 2015. We analyzed the changes of radiologic and pathologic findings during prenatal and postpartum period. Results: 17 of 4978 patients were diagnosed with papillary thyroid cancer. 10 of 17 patients enrolled in this study. Each size of thyroid cancer in 1st trimester, in 2nd trimester, in 3rd trimester, and after delivery was 11.30±6.01 mm, 12.74±7.79 mm, 13.82±9.93 mm, and 13.82±8.19 mm, respectively. No patient showed the recurrence or death after surgery. Conclusion: There was no statistical significance on the prognosis of papillary thyroid cancer during prenatal and postpartum period. The authors propose that the surgical treatment of papillary thyroid cancer diagnosed during pregnancy could be delayed after delivery.
Abstract
Background and Objectives: Although the thyroid cancer occurs in every one of 1000 pregnant women, the optimal timing of surgery is still uncertain. The aim of this study is to propose the timing of surgical management of papillary thyroid cancer in pregnant woman. Materials and Methods: The authors reviewed the medical records of papillary thyroid cancer patients diagnosed during pregnancy in our hospital from May 1st, 2013 to April 30th, 2015. We analyzed the changes of radiologic and pathologic findings during prenatal and postpartum period. Results: 17 of 4978 patients were diagnosed with papillary thyroid cancer. 10 of 17 patients enrolled in this study. Each size of thyroid cancer in 1st trimester, in 2nd trimester, in 3rd trimester, and after delivery was 11.30±6.01 mm, 12.74±7.79 mm, 13.82±9.93 mm, and 13.82±8.19 mm, respectively. No patient showed the recurrence or death after surgery. Conclusion: There was no statistical significance on the prognosis of papillary thyroid cancer during prenatal and postpartum period. The authors propose that the surgical treatment of papillary thyroid cancer diagnosed during pregnancy could be delayed after delivery.
참고문헌 (20)
- Leboulleux S, "Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and", or tumor extension beyond the thyroid capsule at initial diagnosis, 2005, pp.90(10), 5723~5729
- Smith VA, "Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database", J Surg Oncol, 106(4), pp.357~362 (2012)
- The American Joint Committee on Cancer, "AJCC cancer staging manual", pp.87~96 (2010), Springer
- American Thyroid Association Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
- Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26(1), pp.1~133 (2016)
- Randolph GW, "The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension", Thyroid, 22(11), pp.1144~1152 (2012)
- Mazzaferri EL, "Thyroid remnant 131I ablation for papillary and follicular thyroid carcinoma", Thyroid, 7(2), pp.265~271 (1997)
- Castagna MG, "Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients", Eur J Endocrinol, 169(1), pp.23~29 (2013)
- de Meer SG, "Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer", World J Surg, 36(6), pp.1262~1267 (2012)
- Mallick U, "Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer", N Engl J Med, 366(18), pp.1674~1685 (2012)
- Sabra MM, "Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases", Thyroid, 24(7), pp.1088~1095 (2014)
- Pacini F, "Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study", J Clin Endocrinol Metab, 91(3), pp.926~932 (2006)
- Jeon MJ, "Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma", Clin Endocrinol (Oxf), 81(4), pp.593~599 (2014)
- Nixon IJ, "The impact of nodal status on outcome in older patients with papillary thyroid cancer", Surgery, 156(1), pp.137~146 (2014)
- Beierwaltes WH, "An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan", J Nucl Med, 25(12), pp.1287~1293 (1984)
- Schneider DF, "Lymph node ratio predicts recurrence in papillary thyroid cancer", Oncologist, 18(2), pp.157~162 (2013)
- Furtado Mde S, "Persistent and recurrent disease in patients with papillary thyroid carcinoma with clinically apparent (cN1), but not extensive, lymph node involvement and without other factors for poor prognosis", Arch Endocrinol Metab, 59(4), pp.285~291 (2015)
- Schlumberger M, "Strategies of radioiodine ablation in patients with low-risk thyroid cancer", N Engl J Med, 366(18), pp.1663~1673 (2012)
- Sohn SY, "Association between excessive urinary iodine excretion and failure of radioactive iodine thyroid ablation in patients with papillary thyroid cancer", Thyroid, 23(6), pp.741~747 (2013)
- 하승균, "Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer", Journal of Korean Medical Science, 30(7), pp.876~881 (2015), 대한의학회